Tianjin Medical University Cancer Institude and Hospital
Welcome,         Profile    Billing    Logout  
 6 Trials 
2 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Li, Kai
TQB2450-III-09, NCT04964479: A Clinical Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsules Versus K Drug in the Treatment of First-line Non-small Cell Lung Cancer(NSCLC)

Recruiting
3
375
RoW
TQB2450 injection, Anlotinib Hydrochloride Capsules, Pembrolizumab injection, Placebo
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Non Small Cell Lung Cancer
12/22
03/23
NCT04412564: A Study of TQ-B3101 Capsules in Subjects With Advanced Malignant Tumor

Recruiting
2
200
RoW
TQ-B3101
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Advanced Malignant Tumor
03/21
09/21

Download Options